Jefferies Group’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $9.54M | Buy |
1,384,600
+1,231,000
| +801% | +$8.55M | 0.08% | 197 |
|
|
2022
Q2 | $1.28M | Hold |
153,600
| – | – | 0.01% | 727 |
|
|
2022
Q1 | $3.51M | Sell |
153,600
-51,200
| -25% | -$1.25M | 0.02% | 503 |
|
|
2021
Q4 | $5.65M | Buy |
204,800
+187,500
| +1,084% | +$5.02M | 0.03% | 427 |
|
|
2021
Q3 | $482K | Sell |
17,300
-22,700
| -57% | -$644K | ﹤0.01% | 1242 |
|
|
2021
Q2 | $1.17M | Sell |
40,000
-117,000
| -75% | -$3.54M | 0.01% | 941 |
|
|
2021
Q1 | $4.98M | Sell |
157,000
-70,000
| -31% | -$2.05M | 0.04% | 382 |
|
|
2020
Q4 | $4.72M | Buy |
227,000
+60,000
| +36% | +$1.12M | 0.04% | 428 |
|
|
2020
Q3 | $2.6M | Hold |
167,000
| – | – | 0.03% | 474 |
|
|
2020
Q2 | $3.05K | Hold |
167,000
| – | – | 0.04% | 411 |
|
|
2020
Q1 | $2.55M | Sell |
167,000
-223,100
| -57% | -$5.38M | 0.03% | 567 |
|
|
2019
Q4 | $11.7M | Sell |
390,100
-37,800
| -9% | -$983K | 0.09% | 188 |
|
|
2019
Q3 | $9.35M | Buy |
427,900
+204,800
| +92% | +$4.69M | 0.07% | 244 |
|
|
2019
Q2 | $5.63M | Sell |
223,100
-10,000
| -4% | -$237K | 0.04% | 417 |
|
|
2019
Q1 | $5.76M | Sell |
233,100
-427,700
| -65% | -$10.2M | 0.05% | 383 |
|
|
2018
Q4 | $12.2M | Buy |
660,800
+219,700
| +50% | +$5.23M | 0.1% | 159 |
|
|
2018
Q3 | $11.3M | Buy |
441,100
+187,500
| +74% | +$4.29M | 0.07% | 233 |
|
|
2018
Q2 | $5.89M | Sell |
253,600
-1,591,000
| -86% | -$32.9M | 0.03% | 455 |
|
|
2018
Q1 | $29.4M | Sell |
1,844,600
-256,500
| -12% | -$4.77M | 0.16% | 77 |
|
|
2017
Q4 | $43.7M | Buy |
2,101,100
+1,748,200
| +495% | +$27.7M | 0.2% | 60 |
|
|
2017
Q3 | $5.06M | Sell |
352,900
-35,600
| -9% | -$538K | 0.03% | 529 |
|
|
2017
Q2 | $6.72M | Buy |
388,500
+6,300
| +2% | +$75.5K | 0.04% | 403 |
|
|
2017
Q1 | $4.22M | Sell |
382,200
-449,400
| -54% | -$6.18M | 0.03% | 565 |
|
|
2016
Q4 | $12.1M | Buy |
831,600
+652,100
| +363% | +$12M | 0.07% | 282 |
|
|
2016
Q3 | $4.41M | Sell |
179,500
-128,900
| -42% | -$3.34M | 0.02% | 584 |
|
|
2016
Q2 | $6.21M | Sell |
308,400
-261,900
| -46% | -$7.42M | 0.03% | 424 |
|
|
2016
Q1 | $15M | Buy |
570,300
+396,800
| +229% | +$29.3M | 0.09% | 171 |
|
|
2015
Q4 | $17.6M | Buy |
173,500
+159,000
| +1,097% | +$17.9M | 0.1% | 158 |
|
|
2015
Q3 | $2.59M | Sell |
14,500
-26,000
| -64% | -$6.06M | 0.01% | 777 |
|
|
2015
Q2 | $9M | Sell |
40,500
-29,500
| -42% | -$6.54M | 0.05% | 324 |
|
|
2015
Q1 | $13.9M | Sell |
70,000
-507,700
| -88% | -$90.1M | 0.08% | 172 |
|
|
2014
Q4 | $82.7M | Sell |
577,700
-45,900
| -7% | -$6.17M | 0.49% | 34 |
|
|
2014
Q3 | $81.8M | Buy |
623,600
+286,000
| +85% | +$34.1M | 0.56% | 28 |
|
|
2014
Q2 | $42.6M | Buy |
+337,600
| New | +$43.1M | 0.36% | 55 |
|
Other funds holding BHC
IC
PC
GAM
LCM
N
MP
Jefferies Group's BHC Position: Q3 2022 in Review
Jefferies Group increased its Bausch Health (BHC) stake by 218% in Q3 2022, buying an estimated $2.33M and bringing the position to 488,580 shares worth $3.37M. The position accounts for 0.03% of the portfolio, ranked #444.
Jefferies Group first reported a position in BHC in Q2 2013 and has held it in 34 quarters since. The position peaked at $62.5M in Q4 2014. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.
- Jefferies Group held 488,580 shares of Bausch Health worth $3.37M as of Q3 2022.
- Jefferies Group bought 334,985 Bausch Health shares in Q3 2022, an estimated $2.33M.
- Bausch Health made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #444 holding.
- Jefferies Group first reported a position in Bausch Health in Q2 2013 and has held it in 34 quarters since.
- Jefferies Group's Bausch Health position peaked at $62.5M in Q4 2014.
- 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.